Cvetanović, A.S.; Jankovic, K.B.; Stojković, A.S.; Živković, N.D.; Kostić, M.S.; Popović, L.S.
Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer. Cancers 2026, 18, 242.
https://doi.org/10.3390/cancers18020242
AMA Style
Cvetanović AS, Jankovic KB, Stojković AS, Živković ND, Kostić MS, Popović LS.
Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer. Cancers. 2026; 18(2):242.
https://doi.org/10.3390/cancers18020242
Chicago/Turabian Style
Cvetanović, Ana S., Kristina B. Jankovic, Ana S. Stojković, Nikola D. Živković, Miloš S. Kostić, and Lazar S. Popović.
2026. "Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer" Cancers 18, no. 2: 242.
https://doi.org/10.3390/cancers18020242
APA Style
Cvetanović, A. S., Jankovic, K. B., Stojković, A. S., Živković, N. D., Kostić, M. S., & Popović, L. S.
(2026). Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer. Cancers, 18(2), 242.
https://doi.org/10.3390/cancers18020242
